Tessera Defense and Homeland Security Inc. (HLSQ) files reports with the U.S. Securities and Exchange Commission as a NYSE American-listed issuer. These SEC filings document both the company’s current activities as a physical security technology platform and its earlier history as BiomX Inc., a biotechnology business that reported under the PHGE ticker. The registrant’s CIK remains 0001739174 throughout this transition.
Annual reports on Form 10-K and quarterly reports on Form 10-Q provide detail on Tessera’s business description, risk factors, and financial statements. Each report should be read in the context of its reporting period and the business described at that time. Readers should note which periods describe BiomX’s biotechnology operations and which describe Tessera’s security-technology focus.
Current reports on Form 8-K are especially important for understanding key corporate events. An 8-K filed in connection with the September 11, 2026 name and ticker change explains that BiomX Inc. changed its legal name to Tessera Defense and Homeland Security Inc. and that its NYSE American listing transitioned from PHGE to HLSQ. That filing clarifies that the change did not create a new registrant but rebranded the existing company and reflects its shift toward physical security technology.
Other SEC filings, such as registration statements or proxy materials, can provide additional information on capital structure, corporate actions and governance. Historical filings under the BiomX name and PHGE ticker remain part of Tessera’s regulatory record and may be relevant for long-term financial analysis, and subsequent HLSQ filings can be read alongside this retained history to follow the security business.
Tessera Defense & Homeland Security Inc., through its wholly owned Tessera Defense and Homeland Security Israel Ltd., obtained an option from X S.E. Security and Defense Ltd. to buy all X SE shares in RT LTA Systems Ltd., representing 51% of RT’s issued and outstanding share capital on a fully diluted basis. The 90-day option is subject to due diligence satisfactory to Tessera Israel and required approvals; Tessera Israel may terminate by written notice.
Tessera Israel undertook to remit $1,000,000 within 30 days as option consideration, refundable if the option is not exercised or the agreement terminates. If exercised, the purchase price is 51% of RT’s equity value, defined as the lower of $13,000,000 or the sum of twice RT’s average EBITDA and 10% of its average revenue for fiscal years 2026–2028. On exercise, $2,000,000 is payable on account, including the option consideration, with $1,000,000 more at closing; any balance is payable in installments within 30 days after delivery of each year’s audited statements. Tessera Israel may elect to pay in cash, common stock, or both; stock issuance is subject to NYSE American approval, any required stockholder approval, and an available registration exemption. X SE also agreed to cause RT to enter a non-exclusive, perpetual technology license with Tessera Israel within 60 days, whether or not the option is exercised.
Tessera Defense & Homeland Security Inc. (HLSQ) amended its Share Purchase and Option Agreement with Mayers Ventures LLC to increase its planned initial stake in M.E.A. Testing Systems Ltd. from 10% to 15% of MEA’s share capital on a fully diluted basis, subject to listing approval.
The consideration now includes 195,000 Tessera common shares (130,000 issued at closing and 65,000 issuable upon NYSE American authorization), which equals about 4.5% of Tessera’s outstanding common stock. Tessera also established an unsecured up to $475,000 convertible loan to the seller at 12% interest, convertible into MEA shares based on MEA’s 2027 EBITDA or a $10,000,000 valuation, capped at 19.999% total MEA ownership.
Separately, MEA granted Tessera a perpetual, irrevocable, worldwide, fully paid-up and royalty-free license, exclusive for testing, validation and evaluation of unmanned aerial vehicles and propulsion systems and non-exclusive for other defense and security uses. Tessera closed the initial purchase of 324,573 MEA shares (10%) and issued 130,000 Tessera shares on September 16, 2026 under a private placement exemption.
BiomX Inc. (now Tessera Defense and Homeland Security Inc., HLSQ) reports that Mayers Ventures LLC and its owner, Ram Naim, have filed a Schedule 13D disclosing beneficial ownership of 130,000 shares of common stock, or 4.86% of the company’s outstanding shares as of August 19, 2026.
The shares were received as stock consideration for selling 20% (15% plus an additional 5%) of M.E.A. Testing Systems Ltd. to the company under an August 5, 2026 Share Purchase and Option Agreement and a September 16, 2026 amendment. The reporting persons also have a right to an additional 65,000 shares, issuable upon NYSE American authorization, and the company has made available to Mayers Ventures a $475,000 convertible loan facility to fund MEA, bearing 12% annual interest and convertible at the company’s election into MEA shares. The investors state they acquired the stake for investment purposes, may buy or sell more shares, and may engage with management and other shareholders, but do not currently have specific plans for corporate actions listed under Item 4.
BiomX Inc., now Tessera Defense and Homeland Security Inc. (HLSQ), reports that it has effected a one-for-ten reverse stock split of its common stock and changed its corporate name. The reverse split became effective on September 9, 2026, and the name change on September 11, 2026.
The common stock now trades on NYSE American on a split-adjusted basis under the symbol HLSQ with a new CUSIP, replacing PHGE. Management reports stockholders’ equity attributable to the company of $10.9 million and total equity of $17.6 million as of June 30, 2026, levels described as above NYSE American continued listing standards. Over the prior three months the company raised over $4 million through an at-the-market program at an average split-adjusted price of about $2.20 per share, and the reverse split reduced authorized shares from 750 million to 150 million.
The company highlights that its updated corporate presentation and CEO letter outline a strategy focused on an autonomous physical-security platform for homeland security and critical infrastructure, built around subsidiaries Zorronet and DFSL and a minority stake in Motomea. Forward-looking statements acknowledge risks including a history of losses, substantial doubt about its ability to continue as a going concern, and the challenge of regaining and maintaining compliance with NYSE American listing standards within the plan period ending September 25, 2027.
BiomX Inc. (HLSQ), now operating as Tessera Defense & Homeland Security Inc., is the subject of an amended Schedule 13D in which Water IO Ltd., Star 26 Capital Inc., T3 Defense Inc. and Menachem Shalom report their updated holdings. After a one-for-ten reverse stock split effective September 9, 2026, the group holds 156,796 shares of common stock, or 3.87% of the class. This reflects 130,000 shares previously acquired under a securities purchase agreement and 26,796 shares issued on September 15, 2026 as partial interest and consideration under a promissory note amendment. As of September 15, 2026, the reporting persons state they are no longer beneficial owners of more than 5% of the company’s common stock, and this amendment is described as their final, “exit” filing.
BiomX Inc. (PHGE) is implementing a capital and branding change that includes a reverse stock split and a corporate name change. A Certificate of Amendment effective at 12:01 a.m. Eastern Time on September 9, 2026 effects a one-for-ten reverse stock split of the company’s common stock and reduces authorized common shares from 750,000,000 to 150,000,000. Trading in the common stock on the NYSE American will begin on a split-adjusted basis on September 9, 2026 under CUSIP 09090D 608, with fractional shares rounded up to the nearest whole share at the record holder and DTC participant level. A separate amendment will become effective at 12:01 a.m. Eastern Time on September 11, 2026, changing the company’s name from BiomX Inc. to Tessera Defense and Homeland Security Inc., after which the stock will trade under the new ticker symbol HLSQ on the NYSE American while retaining the same CUSIP number.
BiomX Inc. (PHGE) reported that it will change its corporate name to Tessera Defense and Homeland Security Inc., effective at 12:01 a.m. ET on September 11, 2026, following approval by its Board of Directors. Under Delaware law, no stockholder approval is required, and the company plans to file a certificate of amendment to its charter to implement the change.
On September 11, 2026, the common stock will begin trading on the NYSE American under the new ticker symbol HLSQ, and will trade under PHGE until then. The shares will be identified by CUSIP 09090D 608, which is being assigned in connection with a previously announced one-for-ten reverse stock split expected to become effective on September 9, 2026 and will not change as a result of the name change. The company states that the name change and reverse stock split are separate corporate actions, do not affect stockholder rights, and require no action or certificate exchange by stockholders.
BiomX Inc. (PHGE) is implementing a one-for-ten reverse stock split of its common stock. The Board fixed the split ratio at 1-for-10 and expects it to become effective at 12:01 a.m. Eastern Time on September 9, 2026, after filing a Certificate of Amendment in Delaware that also reduces authorized common shares from 750,000,000 to 150,000,000.
Each block of ten pre-split shares will be combined into one post-split share, reducing outstanding common stock from approximately 27.3 million shares as of August 31, 2026 to approximately 2.7 million, without changing par value. Holders of record who would otherwise receive fractional shares will receive one whole share instead, while fractional interests for beneficial owners in street name will be handled under nominee procedures. Proportionate adjustments will apply to outstanding warrants, convertible instruments and equity awards, and the reverse split is expected to affect all stockholders uniformly aside from minor changes from fractional share treatment.
BiomX Inc. (PHGE) announced a 1-for-10 reverse stock split of its common stock. The Board set the ratio on August 28, 2026, after prior stockholder approval of a reverse split in the range of 1-for-5 to 1-for-20, together with a reduction in authorized shares.
The reverse split and related Certificate of Amendment are expected to become effective at 12:01 a.m. ET on September 9, 2026, with trading on the NYSE American beginning on a split-adjusted basis that day. Each 10 pre-split shares will be combined into 1 post-split share, reducing outstanding shares from approximately 26.7 million to approximately 2.7 million, while authorized common shares will decrease from 750,000,000 to 150,000,000. Fractional shares will be rounded up to the next whole share, and percentage ownership will remain essentially unchanged aside from rounding effects.
BiomX Inc. (PHGE) reported results of a Special Meeting of Stockholders held on August 25, 2026. As of the August 10, 2026 record date, 26,559,607 shares of common stock were outstanding and entitled to vote, with 9,813,430 shares present, representing 36.9% of eligible shares and constituting a quorum.
Stockholders approved the issuance of common stock and related securities to Mandragola Ltd. in connection with acquiring controlling equity interests in Dr. Frucht Systems Ltd., including securities linked to a Line of Credit and a potential Revenue Bonus. They also approved a reverse stock split authorization at a ratio between 1-for-5 and 1-for-20, to be implemented at the Board’s discretion before the first anniversary of the Special Meeting; if implemented, authorized common shares would decrease from 750,000,000 to 150,000,000. Stockholders ratified Barzily & Co. as independent registered public accounting firm for the fiscal year ending December 31, 2026 and approved an adjournment proposal, though no adjournment was needed.